Ngaserin Sabrina, Wong Allen Wei-Jiat, Leong Faith Qi-Hui, Feng Jia-Jun, Kok Yee Onn, Tan Benita Kiat-Tee
Breast Service, Department of Surgery, Sengkang General Hospital, Singapore.
SingHealth Duke-NUS Breast Centre, Singapore.
J Breast Cancer. 2023 Apr;26(2):152-167. doi: 10.4048/jbc.2023.26.e10. Epub 2023 Mar 13.
Endoscopic total mastectomy (ETM) is predominantly performed with reconstruction using prostheses, lipofilling, omental flaps, latissimus dorsi flaps, or a combination of these techniques. Common approaches include minimal incisions, e.g., periareolar, inframammary, axillary, or mid-axillary line, which limit the technical ability to perform autologous flap insets and microvascular anastomoses, as such the ETM with free abdominal-based perforator flap reconstruction has not been robustly explored.
We studied female patients with breast cancer who underwent ETM and abdominal-based flap reconstruction. Clinical-radiological-pathological characteristics, surgery, complications, recurrence rates, and aesthetic outcomes were reviewed.
Twelve patients underwent ETM with abdominal-based flap reconstruction. The mean age was 53.4 years (range 36-65). Of the patients, 33.3% were surgically treated for stage I, 58.4% for stage II, and 8.3% for stage III cancer. Mean tumor size was 35.4 mm (range 1-67). Mean specimen weight was 458.75 g (range 242-800). Of the patients, 92.3% successfully received endoscopic nipple-sparing mastectomy and 7.7% underwent intraoperative conversion to skin-sparing mastectomy after carcinoma was reported on frozen section of the nipple base. Mean operative time for ETM was 139 minutes (92-198), and the average ischemic time was 37.3 minutes (range 22-50). Fifty percent of patients underwent deep inferior epigastric perforator, 33.4% underwent MS-2 transverse rectus abdominis musculocutaneous (TRAM), 8.3% underwent MS-1 TRAM, and 8.3% underwent pedicled TRAM flap reconstruction. No cases required re-exploration, no flap failure occurred, margins were clear, and no skin or nipple-areolar complex ischemia/necrosis developed. In the aesthetic outcome evaluation, 16.7% were excellent, 75% good, 8.3% fair, and none were unsatisfactory. No recurrences were observed.
ETM through a minimal-access inferior mammary or mid-axillary line approach, followed by immediate pedicled TRAM or free abdominal-based perforator flap reconstruction, can be a safe means of achieving an "aesthetically scarless" mastectomy and reconstruction through minimal incisions.
内镜全乳切除术(ETM)主要采用假体植入、脂肪填充、网膜瓣、背阔肌瓣或这些技术的联合进行乳房重建。常见的入路包括微小切口,如乳晕周围、乳房下皱襞、腋窝或腋中线切口,这些切口限制了自体皮瓣植入和微血管吻合的技术操作能力,因此,带蒂腹直肌穿支皮瓣重建的ETM尚未得到充分探索。
我们研究了接受ETM和带蒂腹直肌穿支皮瓣重建的乳腺癌女性患者。回顾了临床-放射-病理特征、手术情况、并发症、复发率和美学效果。
12例患者接受了ETM及带蒂腹直肌穿支皮瓣重建。平均年龄为53.4岁(范围36 - 65岁)。其中,33.3%的患者为Ⅰ期手术治疗,58.4%为Ⅱ期,8.3%为Ⅲ期癌症。平均肿瘤大小为35.4 mm(范围1 - 67)。平均标本重量为458.75 g(范围242 - 800)。其中,92.3%的患者成功接受了内镜下保乳手术,7.7%的患者在乳头基底部冰冻切片报告有癌后术中转为保皮全乳切除术。ETM的平均手术时间为139分钟(92 - 198),平均缺血时间为37.3分钟(范围22 - 50)。50%的患者采用腹壁下深动脉穿支皮瓣,33.4%采用MS - 2横腹直肌肌皮瓣(TRAM),8.3%采用MS - 1 TRAM,8.3%采用带蒂TRAM皮瓣重建。无病例需要再次探查,未发生皮瓣坏死,切缘阴性,未出现皮肤或乳头乳晕复合体缺血/坏死。在美学效果评估中,16.7%为优秀,75%为良好,8.3%为一般,无不满意病例。未观察到复发。
通过乳房下皱襞或腋中线小切口入路进行ETM,随后立即进行带蒂TRAM或带蒂腹直肌穿支皮瓣重建,是一种通过微小切口实现“美学无痕”乳房切除和重建的安全方法。